RE: RE: Spikey12 May 2017 19:46
Grayling: you are the one who is incorrect on this. Don't kid yourself. Mateboy is right. From a synical point of view if you were right why would a top pharma like AZN bother to research, develop and market a new drug for lung cancer at huge cost financially and in time. There is a very significant unmet need for these treatments and slowly we are getting better at it after huge effort by the industry and all those who dedicate many years working in the field. I'd like to know where you get your info from regarding lung cancer in non-smokers compared to smokers. It's your statements that need more care not those of Mateboy.